Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats

K Buschard, C Pedersen, S V Hansen, I Hageman, K Aaen, K Bendtzen


Fusidic acid and its sodium salt (fusidin) are anti-staphylococcal drugs. In vitro studies have shown that they prevent the lymphocyte co-stimulatory activities of the cytokines IL-1 and IL-6 in a manner similar to that of cyclosporin A, and prevent the inhibitory effect of IL-1 on glucose-induced insulin production. As IL-1 and IL-6 are thought to play a role in the pathogenesis of Type 1 diabetes, the aim of this study was to investigate whether fusidin could influence the disease incidence of the spontaneously diabetic BB rat model. Accordingly, a group of 50 BB rats receiving fusidin dissolved in their drinking water were compared to a control group of 55 rats over a period of 200 days. The incidence of diabetes was found to be 52% in the experimental group and 71% in the control group (P < 0.05). The degree of insulitis and the number of islets at histological examination were similar among the non-diabetic animals whereas the diabetic fusidin-treated animals showed a higher degree of islet preservation than the diabetic control rats. The results are highly indicative of an anti-diabetogenic effect of fusidin.

Udgave nummer2
Sider (fra-til)101-4
Antal sider4
StatusUdgivet - 1992
Udgivet eksterntJa


Dyk ned i forskningsemnerne om 'Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats'. Sammen danner de et unikt fingeraftryk.